Featured Abstracts and Author Insights

---

ACG 2026 Newsworthy Abstracts Highlight Cutting-Edge Clinical GI Science

EMBARGO: All research presented at ACG 2026 is strictly embargoed until 12:00 pm CT/1:00 pm ET on Sunday, October 11, 2026.

Nominated by the ACG Public Relations Committee, Newsworthy Abstracts feature scientific findings that are innovative, eye-catching to the public, relevant to those who suffer from common GI problems, and which represent a significant advancement in the diagnosis and treatment of GI diseases.

The authors of ACG’s Newsworthy Abstracts, selected by the ACG Public Relations Committee, provide additional perspective on their findings and explain what the clinical science means for patients. Following the links below, reporters can explore these Newsworthy Abstracts and author insights and connect with these researchers for media stories.

= ACG Award Winner

• Higher Sessile Serrated Lesion Detection Rates Are Associated With Lower Risk for Post-Colonoscopy Colorectal Cancer: Data From the New Hampshire Colonoscopy Registry (Oral 2) 
• Efficacy and Safety of Subcutaneous Guselkumab Induction and Maintenance Therapy in Participants With Ulcerative Colitis: Results Through Week 48 From the Phase 3 ASTRO Study (Oral 4)  
• Treatment With Resmetirom for up to Two Years Led to Improvement in Liver Stiffness, Fibrosis Biomarkers, Fibrosis Scores, and Portal Hypertension Risk in 122 Patients With Compensated MASH Cirrhosis (Oral 7)
• Associations Between Early Fluid Resuscitation, SIRS Status, and BUN Changes in Acute Pancreatitis: Real World Results From the APPRENTICE Consortium (Oral 8) 
• Yield of Post-Polypectomy Interval Fecal Immunochemical Testing: Results From a Large Nationwide Veterans’ Affairs Database (Oral 9)
• High Performance of a Blood-Based Biomarker Test to Detect Early-Stage Pancreatic Cancer in a High-Risk Population, Across Two Independent Clinical Validation Studies (Oral 18)
• Does Mild Endoscopic Disease Drive Persistent Symptoms in Crohn’s Disease? A Repeated Measures Analysis (Oral 24)
• Comparative Efficacy of Tirzepatide vs. Semaglutide on Liver and Cardiovascular Related Outcomes in Patients with MASLD/MASH, Obesity, and Type 2 Diabetes Mellitus: A Real-World Cohort Study (Oral 31)
• Early versus Delayed Cholecystectomy in Patients Admitted for Choledocholithiasis: Impact on Biliary Complications and Role of Sphincterotomy or Stenting (Oral 35) 
• Real-World Study of Biopsy Practices During Food Impactions in the Emergency Department: Multi-State GI Practice (Oral 46) 
• Early Colon Adenoma Development Following Immune Checkpoint Inhibitor Colitis: Implications for Prompt Surveillance Colonoscopy (Oral 53) 
• Duvakitug, an anti-TL1a mAb, Demonstrates Efficacy and Favorable Safety as an Induction Treatment in Adults With Moderately to Severely Active Crohn’s Disease: Results From the RELIEVE UCCD Phase 2b Basket Trial (Oral 66)
• Real World Outcomes of Upadacitinib Compared to Risankizumab as Second-Line Therapy in Patients With Crohn’s Disease Exposed to Tumor Necrosis Factor-Alpha Inhibitors (Oral 72)
• Early Signs of Pancreas Adenocarcinoma Are Often Missed on Cross-Sectional Imaging: Results From a Multicenter Cohort Study (P0080)
• Comparing Different Elimination Diets in the Treatment of Eosinophilic Esophagitis: A Systematic Review and Network Meta-Analysis (P0612)
• Bone Density and Fracture Risk in Vonoprazan Users: A Stratified Population-Based Analysis (P0616)
• Transforming Gastrointestinal Cancer Care Through Artificial Intelligence: Breaking Barriers With Patient-Friendly Education (P1912)
• Second-hand Smoke: A Silent Culprit Behind Peptic Ulcer Disease (P2040) 
• The Impact of a Patient Navigation System on Colonoscopy Completion Rates (P4788)
• Metabolic and Bariatric Surgery vs Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Head-to-Head Comparison of Cardiometabolic Risk Profile (P4844)
• Oral Vonoprazan Is Noninferior to Intravenous Proton Pump Inhibitors for Peptic Ulcer Rebleeding: A Matched Cohort Analysis of Clinical Outcomes (P5201) 
• Implementation of a Nurse Practitioner-Led Rapid Access Clinic for Patients With Inflammatory Bowel Disease: A Quality Improvement Project (P5314) 
• A Vegan and Allergy-Friendly Alternative for Gastric Emptying Scintigraphy: Validation in Healthy Participants (P6310) 

To view ACG press releases, visit Media Statements.